Kandhi S et al. |
EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice. |
2016 |
Am. J. Hypertens. |
pmid:26304959
|
Wang X et al. |
CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure. |
2014 |
Mol. Pharmacol. |
pmid:24145329
|
Althurwi HN et al. |
Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy. |
2014 |
J. Cardiovasc. Pharmacol. |
pmid:24157956
|
Diani-Moore S et al. |
Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA. |
2014 |
Drug Metab. Dispos. |
pmid:24311719
|
Strauss KI et al. |
Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:22922090
|
Cracowski JL et al. |
Involvement of cytochrome epoxygenase metabolites in cutaneous postocclusive hyperemia in humans. |
2013 |
J. Appl. Physiol. |
pmid:23172029
|
Klett EL et al. |
Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion. |
2013 |
J. Biol. Chem. |
pmid:23766516
|
Liu Y et al. |
A soluble epoxide hydrolase inhibitor--8-HUDE increases pulmonary vasoconstriction through inhibition of K(ATP) channels. |
2012 |
Pulm Pharmacol Ther |
pmid:22155000
|
Gao Y et al. |
8,9-Epoxyeicosatrienoic acid inhibits antibody production of B lymphocytes in mice. |
2012 |
PLoS ONE |
pmid:22802958
|
Norton SK et al. |
Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma. |
2012 |
J. Allergy Clin. Immunol. |
pmid:22664166
|